Regent Peak Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Regent Peak Wealth Advisors's LLY Position: Q2 2026 in Review
Regent Peak Wealth Advisors increased its Eli Lilly (LLY) stake by 4.2% in Q2 2026, buying an estimated $123K and bringing the position to 2,995 shares worth $3.59M. The position accounts for 0.67% of the portfolio, ranked #23.
Regent Peak Wealth Advisors first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Regent Peak Wealth Advisors held 2,995 shares of Eli Lilly worth $3.59M as of Q2 2026.
- Regent Peak Wealth Advisors bought 120 Eli Lilly shares in Q2 2026, an estimated $123K.
- Eli Lilly made up 0.67% of Regent Peak Wealth Advisors's portfolio in Q2 2026, its #23 holding.
- Regent Peak Wealth Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
- 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Regent Peak Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.